Soon-Chan Kim

I am an Assistant Professor of Bio-Medical AI in the School of AI and Data Science at the University of Suwon. My research applies artificial intelligence to translational oncology — specifically, hit-to-lead optimization, computational drug efficacy screening, prediction of optimal treatment, AI-based multi-omics, and disease modeling with patient-derived organoid and cell-line panels.

I received my PhD in Biomedical Sciences from Seoul National University College of Medicine (2020) under the mentorship of Prof. Ja-Lok Ku, and my BS in Integrative Biology from UC Berkeley (2013). Before joining Suwon University in March 2025, I was a Research Assistant Professor at the Seoul National University Medical Research Center, where I led the establishment and multi-omics characterization of large-scale biobanks of organoids and cell lines from colorectal, pancreatic, breast, lung, glioblastoma, and sarcoma patients — the empirical foundation on which my current computational work builds.

Selected Publications

1. Kim SC^†, Kim GH^†, et al. Establishment and characterization of 24 breast cancer cell lines and 3 breast cancer organoids reveals molecular heterogeneity and drug response variability in malignant pleural effusion-derived models. Breast Cancer Res. 2025;27(1):66.
2. Kim SC^†, Seo HY^†, et al. Establishment, characterization, and biobanking of 36 pancreatic cancer organoids: prediction of metastasis in resectable pancreatic cancer. Cell Oncol (Dordr). 2024;47(5):1627–1647.
3. Kim SC^†, Kim MJ^†, et al. Effects of simulated microgravity on colorectal cancer organoids growth and drug response. Sci Rep. 2024;14(1):25526.
4. Kim SC, Cho YE, et al. Patient-derived glioblastoma cell lines with conserved genome profiles of the original tissue. Sci Data. 2023;10(1):448.
5. Kim SC, Park JW, et al. Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses. Adv Sci (Weinh). 2022;9(5):e2103360.
6. Kim SC^†, Kim HS^†, et al. Establishment and characterization of 18 human colorectal cancer cell lines. Sci Rep. 2020;10(1):6801.

^† Equal contribution. See all 17 publications →